This finding, found also in other studies [3,4,11,33,34], indicates that the prescription of drugs for CHF with rEF is not optimal and, therefore, that the recommendations of the CPG for the use of renin-angiotensin-aldosterone system blockers and of BB have not yet been implemented in Spanish PC. The gene discussed is REN; the disease is congestive heart failure.